Dr Lucio D’Anna is a Consultant Neurologist at the Department of Stroke & Neurosciences at Imperial College London NHS Trust. He is also Honorary Senior Lecturer at the Division of Brain Sciences, Imperial College London.
There is a wide range of variation in the first presentation of symptoms for people carrying the HD gene, and much is still unknown about the way the disease progresses from initial signs to development of overt motor symptoms.
As the disease progresses, involuntary movement, emotional changes and memory disturbances will become more severe. Although some symptoms can be managed with medications, there is no current treatment that can reverse its progression or slow it down.
At Dementech Neurosciences, we offer a multidisciplinary approach to treat all the variety of symptoms of Huntington’s disease (aka HD). We have in-house speech and language therapist, occupational therapist, dietitian, psychologist and psychiatrist to manage effectively HD symptoms and complications.
We use state-of-the-art technology such as the PKG to monitor and treat HD symptoms. Neuropsychiatric and cognitive impairment may occur even at the early stage of the disease before the development of motor symptoms.
Cutting-edge technology CANTAB is used to assess the severity of cognitive deficits in people with Huntington’s disease. This enables us to provide an early diagnosis of cognitive impairment and effectively manage it. We also provide genetic screening and counselling for the family carrying the HD gene expansion mutation.
Moreover, we offer the opportunity to participate in clinical trials testing novel pharmacological intervention, before they become available to the public, aiming to delay the progression of the disease.